Increased phosphorylation and activation of mitogen-activated protein kinase p38 in scleroderma fibroblasts

Journal of Investigative Dermatology

Volumn 125, Issue 2, 2005, Pages 247-255

  Ihn, Hironobu ^a   Yamane, Kenichi ^a   Tamaki, Kunihiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Fibronectin; Gene expression; Procollagen; Signal transduction; Transcription factors

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN; COLLAGEN TYPE 1; FIBRONECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; ALPHA 2(I) COLLAGEN; ENZYME INHIBITOR;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXTRACELLULAR MATRIX; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; SCLERODERMA; SIGNAL TRANSDUCTION; SYSTEMIC SCLEROSIS; ADULT; CELL CULTURE; CYTOLOGY; DERMIS; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENETIC TRANSCRIPTION; GENETICS; MALE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

ADULT; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE I; DERMIS; ENZYME INHIBITORS; FEMALE; FIBROBLASTS; FIBRONECTINS; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; SCLERODERMA, SYSTEMIC; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 24344471061     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23766.x     Document Type: Article

References (41)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR: PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494, 1995
2. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 331:1286-1292, 1994
3. Bornstein P, Sage H: Structurally distinct collagen types. Annu Rev Biochem 49:957-1003, 1980
4. Chang E, Goldberg H: Requirements for transforming growth factor-β regulation of the pro α2(I) collagen and plasminogen activator inhibitor-1 promoters. J Biol Chem 270:4473-4477, 1995
5. Chen S-J, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J: Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β: Involvement of Smad 3. J Invest Dermatol 112:49-57, 1999
6. Chung KY, Agarwal A, Uitto J, Mauviel A: An AP-1 binding sequence is essential for regulation of the human α2(I) collagen promoter activity by transforming growth factor-β. J Biol Chem 271:3272-3278, 1996
7. Dudly DT, Pang L, Decker ST, Bridges AJ, Saltier AR: A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci USA 92:7686-7689, 1995
8. Ghosh AK, Yuan W, Mori Y, Varga J: Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-β involves functional cooperation with p300/CBP transcriptional coactivators. Oncogene 19:3546-3455, 2000
9. Greenwel P, Inagaki Y, Hu W, Walsh M, Rramirez F: Sp1 is required for the early response of α2(I) collagen to transforming growth factor-β1. J Biol Chem 272:19738-19745, 1997
10. Ignotz RA, Endo T, Massaguë J: Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-β. J Biol Chem 262:6443-6446, 1987
11. Ihn H, Ihn Y, Trojanowska M: Sp1 phosphorylation induced by serum stimulates the human α2(I) collagen gene expression. J Invest Dermatol 117: 301-308, 2001a
12. Ihn H, LeRoy EC, Trojanowska M: Oncostatin M stimulates transcription of the human α2(I) collagen gene via the Sp1/Sp3-binding site. J Biol Chem 272:24666-24672, 1997
13. Ihn H, Ohnishi K, Tamaki T, LeRoy EC, Trojanowska M: Transcriptional regulation of the human α2(I) collagen gene: Combined action of upstream stimulatory and inhibitory cis-acting elements. J Biol Chem 271:26717-26723, 1996
14. Ihn H, Tamaki K: Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts: Association with increased expression of the type I collagen gene. Arthritis Rheum 43:2240-2247, 200Oa
15. Ihn H, Tamaki K: Competition analysis of the human α 2(I) collagen promoter using synthetic oligonucleotides. J Invest Dermatol 114:1011-1016, 2000b
16. Ihn H, Tamaki K: Oncostatin M stimulates the growth of dermal fibroblasts via a mitogen-activated protein kinase-dependent pathway. J Immunol 165: 2149-2155, 2000c
17. Ihn H, Trojanowska M: Sp3 is a transcriptional activator of the human α2(I) collagen gene. Nucleic Acids Res 25:3712-3717, 1997
18. Ihn H, Yamane K, Asano Y, Kubo M, Tamaki K: Interleukin-4 up-regulates the expression of tissue inhibitor of metalloproteinase-2 in dermal fibroblasts via the p38 mitogen-activated protein kinase-dependent pathway. J Immunol 168:1895-1902, 2002
19. Ihn H, Yamane K, Kubo M, Tamaki K: Blockade of endogenous transforming growth factor β signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts. Association with increased expression of transforming growth factor β receptors. Arthritis Rheum 44:474-480, 2001b
20. Inagaki Y, Truter S, Ramirez F: Transforming growth factor-β stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem 269:14828-14834, 1994
21. Inagaki Y, Truter S, Tanaka S, DiLiberto M, Ramirez F: Overlapping pathways mediate the opposing actions of tumor necrosis-α and transforming growth factor-β on α2(I) collagen gene transcription. J Biol Chem 270:3353-3358, 1995
22. Jelaska A, Arakawa M, Broketa G, Korn JH: Heterogeneity of collagen synthesis in normal and systemic sclerosis skin fibroblasts: Increased proportion of high collagen-producing cells in systemic sclerosis fibroblasts. Arthritis Rheum 39:1338-1346, 1996
23. Kähäri VM, Chen YQ, Su MW, Ramirez F, Uitto J: Tumor necrosis factor-α and interferon-γ suppress the activation of human type I collagen gene expression by transforming growth factor-β1. J Clin Invest 86:1489-1495, 1990
24. Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K: Smads proteins exist as monomers in vivo and undergo homo- and hetro-oligomerization upon activation by serine/threonine kinase receptor. EMBO J 17:4056-4065, 1998
25. Kretzschmar M, Massaguë J: SMADs: Mediators and regulators of TGF-β signaling. Curr Opin Genet Dev 8:103-111, 1998
26. Kyriakis JM, Avruch J: Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 271:24313-24316, 1996
27. LeRoy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM: A strategy for determining the pathogenesis of systemic sclerosis: Is transforming growth factor β the answer? Arthritis Rheum 32:817-825, 1989
28. Massaguë J: The transforming growth factor-β family. Annu Rev Cell Biol 6: 597-641, 1990
29. Matsumoto T, Yokote K, Tamura K, Takemoto M, Ueno H, Saito Y, Mori S: Platelet-derived growth factor activates p38 mitogen-activated protein kinase through a Ras-dependent pathway that is important for actin reorganization and cell migration. J Biol Chem 274:13954-13960, 1999
30. Poncelet AC, Schnaper HW: Sp1 and Smad proteins cooperate to mediate transforming growth factor-β1-induced α2(I) collagen expression in human glomerular mesangimal cells. J Biol Chem 276:6983-6992, 2001
31. Ramirez F, DiLiberto M: Complex and diversified regulatory programs control the expression of vertebrate collagen genes. FASEB J 4:16116-23, 1990
32. Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J, Kahari VM: Transforming growth factor-β induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 274:37292-37300, 1999b
33. Ravanti L, Heino J, Lopez-Otin C, Kahari VM: Induction of collagenase-3 (MMP-13) expression in human dermal fibroblasts by three dimensional collagen is mediated by p38 mitogen-activated protein kinase. J Biol Chem 274:2446-2455, 1999a
34. Roberts AB, Heine UI, Flanders KC, Sporn MB: Transforming growth factor-β. Major role in regulation of extracellular matrix. Ann NY Acad Sci 58: 225-232, 1990
35. Roberts AB, Sporn MB: Physiological actions and clinical applications of transforming growth factor-β (TGF-β). Growth Factors 8:1-9, 1993
36. Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B: A nuclear factor I binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-β. Cell 52: 405-415, 1988
37. Sato M, Shegogue D, Gore EA, Smith EA, Mcdermott PJ, Trojanowska M: Role of p38 MAPK in transforming growth factor β stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J Invest Dermatol 118:704-711, 2002
38. Vuorio E, de Crombrugghe B: The family of collagen genes. Annu Rev Biochem 59:832-837, 1990
39. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, Chien KR: Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273:2161-2168, 1998
40. Yamane K, Ihn H, Kubo M, Tamaki K: Increased transcriptional activities of transforming growth factor-β receptors in scleroderma fibroblasts. Arthritis Rheum 46:2421-2428, 2002
41. Zhang W, Ou J, Inagaki Y, Greenwel P, Ramirez F: Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor-β1 stimulation of α2(I) collagen (Col1A2) transcription. J Biol Chem 275:39237-39245, 2000